2024. METABOLIC REPROGRAMMING IN HEPATOCELLULAR CARCINOMA: TARGETING MITOCHONDRIAL BIOGENESIS. Journal of Biological and Medical Innovations. 2, 2 (Dec. 2024), 1–13.